BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld Asia
Home
» Other news to note for April 6, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for April 6, 2021
April 6, 2021
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Affamed, Ajinomoto, Anixa, Arbutus, Aspect Biosystems, Astellas Gene Therapies, Bright Peak, Celonic, Chromadex, Claritas, Curevac, Emergent Biosolutions, Frontier, Glaxosmithkline, Gracell, Iconovo, Immune System Regulation, Immuneoncia, Johnson & Johnson, JSR, Lianbio, Novavax, Ontochem, Ovid, Panacea, Proteros Biostructures, Recce, Sifi, Sinovac, Sumitomo Dainippon, Takeda, Tarsus, Telix, Teva, Vir.
BioWorld Asia
Briefs
Other news to note